Related Experiment Video
Updated: Mar 16, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Prevalence of Pneumocystis jirovecii colonization in autopsy cases in Turkey
Soykan Özkoç1, Murat Köker2, Mustafa Önder2
1Department of Parasitology, Dokuz Eylül University, Faculty of Medicine, Izmir, Turkey.
Abstract:
Detection of Pneumocystis jirovecii and its DNA in clinically asymptomatic people is defined as colonization. The aim of this study was to reveal the colonization prevalence of P. jirovecii and affecting factors in an immunocompetent population. The study included 200 cases undergoing forensic autopsy between February 2015 and April 2015. The cause of death was non-medical conditions (group 1) in 111 cases (55.5 %), medical conditions (group 2) in 73 cases (36.5 %) and undetermined (group 3) in 16 cases (group 3). Tissue specimens about 1 g in weight were taken from the right upper pulmonary lobe. After DNA extraction, nested PCR targeting mitochondrial large subunit rRNA was used to detect P. jirovecii. Of 200 cases, 37 (18.5 %) had P. jirovecii DNA. There was not a significant difference in place of living, gender, smoking status and medication use between the cases with P. jirovecii and those without P. jirovecii. A significantly high rate of P. jirovecii colonization was detected in group 2 (χ²=7.674; P=0.022). P. jirovecii-colonized cases also had a chronic disease in 2 of 13 (group 1), 12 of 20 (group 2) and 1 of 4 (group 3) cases (χ²=5.571; P=0.062). A significantly high rate of the cases aged 0-1 year had P. jirovecii (5/11; 45.5 %) (χ²=5.639; P=0.018). The results of the study suggest that infants and patients with chronic diseases like cardiac or pulmonary diseases can be at risk for P. jirovecii colonization.
Insights
Pneumocystis jirovecii colonization was detected in 18.5% of asymptomatic individuals. Infants and those with chronic diseases showed higher colonization rates, suggesting increased risk.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Pneumocystis jirovecii colonization, defined as its DNA detection in asymptomatic individuals, is a growing concern.
- Understanding colonization prevalence in immunocompetent populations is crucial for public health strategies.
Purpose of the Study:
- To determine the prevalence of Pneumocystis jirovecii colonization in an immunocompetent population.
- To identify factors associated with P. jirovecii colonization in this demographic.
Main Methods:
- Nested PCR targeting the mitochondrial large subunit rRNA gene was employed.
- DNA was extracted from lung tissue specimens of 200 individuals undergoing forensic autopsy.
- Cases were categorized based on cause of death: non-medical, medical, and undetermined.
Main Results:
- Pneumocystis jirovecii DNA was detected in 18.5% (37/200) of the studied cases.
- Significantly higher colonization rates were observed in cases with medical causes of death (P=0.022).
- Infants aged 0-1 year (45.5%) and individuals with chronic diseases (particularly cardiac or pulmonary) showed elevated colonization rates.
Conclusions:
- The study highlights a significant prevalence of P. jirovecii colonization in immunocompetent individuals.
- Infants and patients with chronic conditions represent at-risk groups for P. jirovecii colonization.
- Further research into risk factors and clinical implications of colonization in these populations is warranted.
Related Concept Videos
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

